Canada Atopic Dermatitis Market Analysis

$2,350.00$4,700.00

  • Type: Common Disease Area
  • Published : April 2021
  • Region: North America
  • Country: Canada
  • Report ID : 3134

  • Format: PPT, PDF

Canada Atopic Dermatitis Drugs Market: Segmented by Drug Class (Calcineurin Inhibitors, Corticosteroids, Phosphodiesterase4 (PDE4) inhibitors, Biologics, & Others) and by Route of Administration (Topical, Injectable, & Oral)- Growth, Trends, And Forecasts (2019 – 2028)

Clear
SKU: 3134 Categories: ,

The Canada Atopic Dermatitis Drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Atomic Dermatitis (AD) is a chronic inflammatory skin condition marked by periods of flare (i.e. dry, red, itchy skin that can crack, ooze, and bleed) and periods of remission or disease improvement. The symptoms can lead to lack of sleep, low self-esteem and cause a significant negative impact on quality of life. It is estimated that 11% of children and 7% of adults live with the disease in Canada. Eczema Society of Canada (ESC) surveyed patients and caregivers and revealed some key challenges Canadians face. 41% of adults with AD are in a constant state of flare. They may experience some improvement of their symptoms but never experience periods of fully clear skin. Nearly half (48%) of adults with AD have experienced an eczema flare ‘crisis’ that required immediate medical intervention. Timing to see a specialist during a flare is a challenge, with 37% of adult patients and 42% of caregivers worrying they won’t see their health care provider during an eczema flare.

Market Drivers

The market is anticipated to progress at a modest pace through the forecast period. The launch of more biologics & small molecules, premium-priced drugs replacing the generic first line and second-line therapeutics, growing incidence of AD, and improved diagnostics are estimated to stoke the market’s growth. The rise in awareness regarding the availability of treatments for the disease has helped the market gain traction over the past few years. Initiatives undertaken by governments to provide better and more affordable treatment and the presence of favourable reimbursement policies are likely to provide an upthrust to the market. Furthermore, the growing acceptance of targeted therapies such as Eucrisa and Dupixent also favours the market.

1. Canada Atopic Dermatitis Drugs Market Overview………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in Prevalence of Atopic Dermatitis
B. Growing R&D Investments and Reimbursement Policies
3. Epidemiology……………………………………………….
A. Prevalence, Incidence, and Management of Atopic Dermatitis
4. Atopic Dermatitis Drugs Market Segmentation ………………………………………
A. By Drug Class
I. Calcineurin Inhibitors
II. Corticosteroids
III. Phosphodiesterase4 (PDE4) inhibitors
IV. Biologics
V. Others
B. By Route of Administration
I. Topical
II. Injectable
III. Oral
5. Atopic Dermatitis Major Drugs Market Share……………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Novartis AG Company overview, Product & Services, Strategies & Financials
B. Sanofi Company overview, Product & Services, Strategies & Financials
C. Pfizer Inc Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………….
A. New Trends and Development of Atopic Dermatitis Drugs Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

Based on drug class, the market is divided into corticosteroids, calcineurin inhibitors, phosphodiesterase4 (PDE4) inhibitors, biologics, and others. Corticosteroids have been the mainstay for AD treatment. Novel drug classes, such as PDE4 inhibitors and biologics, are expected to gain tremendous popularity over the forecast period on account of the increasing adoption of targeted therapy and the launch of pipeline candidates.  Biologics are mainly prescribed for severe cases as the second or third line of treatment after the patient has shown insufficient or no response to prior therapies.

By Route of Administration:

Based on administration, the atopic dermatitis drug market can be segmented into topical, injectable, and oral. Topical corticosteroids are the most widely prescribed medications for AD. They are often administered in combination with moisturizers or emollients for more effective results. Although topicals are estimated to maintain their lead, injectables are likely to be the fastest-growing segment during the forecast period. Antibiotics, antihistamines, and anti-inflammatory agents are generally administered by oral route.

 Major Players

Investment in the research and development of new pharmaceutical drugs is the critical strategy for the companies’ market expansion. Recently, Health Canada approved DUPIXENT (dupilumab injection) by Sanofi. It is the first biologic for treating moderate-to-severe atopic dermatitis in children aged 6 to 11 years. DUPIXENT is a fully human monoclonal antibody that inhibits the interleukin-4 (IL-4) signalling and interleukin-13 (IL-13) proteins and is not an immunosuppressant.

Some of the key players operating in the market are Bayer, LEO Pharma, Mylan, Pfizer, Teva Pharmaceutical Industries Ltd, Novartis AG, and Sanofi.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

Download Free Sample Report






    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements